United Kingdom · Question · Written question
UIN 141473
Coronavirus: Vaccination
Introduced
21 January 2021
Last action
30 March 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 March 2021
Summary
To ask the Secretary of State for Health and Social Care, whether the relative proportions of Pfizer-BioNTech and Oxford/AstraZeneca vaccine, as a proportion of total vaccine supply, being distributed (a) to regions within England and (b) to the devolved
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 January 2021
Written question
To ask the Secretary of State for Health and Social Care, whether the relative proportions of Pfizer-BioNTech and Oxford/AstraZeneca vaccine, as a proportion of total vaccine supply, being distributed (a) to regions within England and (b) to the devolved
Source: Commons
30 March 2021
Answer
The proportion of Pfizer-BioNTech to Oxford/AstraZeneca vaccines may vary between sites/regions due to logistical imperatives such as storage and wider national supply.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-01-21/141473
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1279277
- uk · wq-1279277 · source updated 30 March 2021